Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice

Blood

Volumn 118, Issue 26, 2011, Pages 6909-6919

  Hegde, Shailaja ^a   Kaushal, Naveen ^a   Ravindra, Kodihalli C ^a   Chiaro, Christopher ^a   Hafer, Kelsey T ^a   Gandhi, Ujjawal H ^a   Thompson, Jerry T ^a   Van Den Heuvel, John P ^a   Kennett, Mary J ^a   Hankey, Pamela ^a   Paulson, Robert F ^a   Prabhu, K Sandeep ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,8,11,14,17 ICOSAPENTAENOIC ACID; BCR ABL PROTEIN; CD45 ANTIGEN; DELTA12 PROSTAGLANDIN J3; LIPOCORTIN 5; OMEGA 3 FATTY ACID; ONCOPROTEIN; PROSTAGLANDIN; PROSTAGLANDIN J2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW; CANCER STEM CELL; CELL CULTURE; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG TARGETING; ERYTHROLEUKEMIA CELL; LEUKEMIA CELL; LEUKOCYTE COUNT; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; SPLEEN; SPLENOMEGALY; TUMOR ABLATION;

EID: 84255197255     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-11-317750     Document Type: Article

References (41)

1. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and proresolution lipid mediators. Nat Rev Immunol. 2008;8(5):349-361. (Pubitemid 351595216)
2. Serhan CN, Yacoubian S, Yang R. Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol. 2008;3:279-312. (Pubitemid 351488283)
3. Terry P, Lichtenstein P, Feychting M, Ahlbom A, Wolk A. Fatty fish consumption and risk of prostate cancer. Lancet. 2001;357(9270):1764-1766. (Pubitemid 32524210)
4. Vanamala J, Glagolenko A, Yang P, et al. Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARdelta/PGE2 and elevation of PGE3. Carcinogenesis. 2008; 29(4):790-796. (Pubitemid 351494167)
5. Serhan CN, Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol. 2008; 153(suppl 1):S200-S215. (Pubitemid 351340979)
6. Wada M, DeLong CJ, Hong YH, et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem. 2007;282(31):22254-22266. (Pubitemid 47267340)
7. Urade Y, Hayaishi O. Prostaglandin D synthase: structure and function. Vitam Horm. 2000;58:89- 120.
8. Fitzpatrick FA, Wynalda MA. Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J Biol Chem. 1983; 258(19):11713-11718. (Pubitemid 13019315)
9. Shibata T, Kondo M, Osawa T, Shibata N, Kobayashi M, Uchida K. 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. J Biol Chem. 2002;277(12):10459-10466. (Pubitemid 34968167)
10. Kobayashi M, Ono H, Mihara K, et al. ATM activation by a sulfhydryl-reactive inflammatory cyclopentenone prostaglandin. Genes Cells. 2006; 11(7):779-789. (Pubitemid 43923349)
11. Rossi A, Kapahi P, Natoli G, et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature. 2000;403(6765): 103-108. (Pubitemid 30038530)
12. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 1995; 83(5):803-812. (Pubitemid 3006324)
13. Hassane DC, Guzman ML, Corbett C, et al. Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data. Blood. 2008;111(12):5654-5662.
14. Rosen JM, Jordan CT. The increasing complexity of the cancer stem cell paradigm. Science. 2009; 324(5935):1670-1673.
15. Ben-David Y, Bernstein A. Friend virus induced erythroleukemia and the multistage nature of cancer. Cell. 1991;66:831-834. (Pubitemid 121001718)
16. Schemionek M, Elling C, Steidl U, et al. BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells. Blood. 2010; 115(16):3185-3195.
17. Pear WS, Miller JP, Xu L, et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood. 1998; 92(10):3780-3792. (Pubitemid 28525205)
18. Hu Y, Swerdlow S, Duffy TM,Weinmann R, Lee FY, Li S. Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice. Proc Natl Acad Sci U S A. 2006;103(45):16870-16875. (Pubitemid 44737345)
19. Zhao C, Chen A, Jamieson CH, et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature. 2009; 458(7239):776-779.
20. Subramanian A, Hegde S, Porayette P, Yon M, Hankey P, Paulson RF. Friend virus utilizes the BMP4-dependent stress erythropoiesis pathway to induce erythroleukemia. J Virol. 2008;82(1): 382-393. (Pubitemid 350309153)
21. Harandi OF, Hedge S, Wu DC, McKeone D, Paulson RF. Murine erythroid short-term radioprotection requires a BMP4-dependent, selfrenewing population of stress erythroid progenitors. J Clin Invest. 2010;120(12):4507-4519.
22. Vunta H, Davis F, Palempalli UD, et al. The antiinflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. J Biol Chem. 2007;282(25):17964- 17973.
23. Chesebro B, Wehrly K, Cloyd M, et al. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens. Virology. 1981;112(1):131-144. (Pubitemid 11069765)
24. Mager DL, Mak TW, Bernstein A. Quantitative colony method for tumorigenic cells transformed by two distinct strains of Friend leukemia virus. Proc Natl Acad Sci U S A. 1981;78(3):1703-1707. (Pubitemid 11114250)
25. Finkelstein L, Ney P, Liu Q, Paulson R, Correll P. Sf-Stk kinase activity and the Grb2 binding site are required for Epo-independent growth of primary erythroblasts infected with Friend virus. Oncogene. 2002;21:3562-3570. (Pubitemid 34587688)
26. Feldon SE, O'LoughlinCW, Ray DM, Landskroner- Eiger S, Seweryniak KE, Phipps RP. Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. Am J Pathol. 2006;169(4):1183-1193. (Pubitemid 351194355)
27. Na HK, Surh YJ. Transcriptional regulation via cysteine thiol modification: a novel molecular strategy for chemoprevention and cytoprotection. Mol Carcinog. 2006;45(6):368-380.
28. Nolte RT, Wisely GB, Westin S, et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature. 1998;395(6698):137-143. (Pubitemid 28425645)
29. Persons DA, Paulson RF, Loyd MR, et al. Fv2 encodes a truncated form of the Stk receptor tyrosine kinase. Nat Genet. 1999;23(2):159-165. (Pubitemid 29455387)
30. Subramanian A, Teal HE, Correll PH, Paulson RF. Resistance to friend virus-induced erythroleukemia in W/W(v) mice is caused by a spleenspecific defect which results in a severe reduction in target cells and a lack of Sf-Stk expression. J Virol. 2005;79(23):14586-14594. (Pubitemid 41636257)
31. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 2003;421(6922): 499-506. (Pubitemid 36168436)
32. Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 1998;12(19):2973-2983. (Pubitemid 28469299)
33. Lavin MF, Kozlov S. ATM activation and DNA damage response. Cell Cycle. 2007;6(8):931- 942.
34. Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev. 2010; 68(5):280-289.
35. Norling LV, Serhan CN. Profiling in resolving inflammatory exudates identifies novel antiinflammatory and pro-resolving mediators and signals for termination. J Intern Med. 2010; 268(1):15-24.
36. Kulkarni PS, Srinivasan BD. The effect of intravitreal and topical prostaglandins on intraocular inflammation. Invest Ophthalmol Vis Sci. 1982; 23(3):383-392. (Pubitemid 12020691)
37. Kulkarni PS, Srinivasan BD. Eicosapentaenoic acid metabolism in human and rabbit anterior uvea. Prostaglandins. 1986;31(6):1159-1164. (Pubitemid 16051991)
38. Kulkarni PS, Srinivasan BD. Cyclooxygenase and lipoxygenase pathways in anterior uvea and conjunctiva. Prog Clin Biol Res. 1989;312:39-52.
39. Fujimori K, Kanaoka Y, Sakaguchi Y, Urade Y. Transcriptional activation of the human hematopoietic prostaglandin D synthase gene in megakaryoblastic cells. Roles of the oct-1 element in the 5′-flanking region and the AP-2 element in the untranslated exon 1. J Biol Chem. 2000;275(51): 40511-40516. (Pubitemid 32064688)
40. Shin SW, Seo CY, Han H, et al. 15d-PGJ2 induces apoptosis by reactive oxygen speciesmediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity. Clin Cancer Res. 2009;15(17):5414- 5425.
41. Kim DH, Kim EH, Na HK, Sun Y, Surh YJ. 15- Deoxy-Delta(12,14)- prostaglandin J(2) stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue. Oncogene. 2010;29(17): 2560-2576.